Long-term Efficacy and Safety of Rifampin in the Treatment of a Patient Carrying a CYP24A1 Loss-of-Function Variant.
Alessandro BrancatellaDaniele CappellaniMartin KaufmannAntonella SemeraroSimona BorsariChiara SardellaFulvia BaldinottiMaria Adelaide CaligoGlenville JonesClaudio MarcocciFilomena CetaniPublished in: The Journal of clinical endocrinology and metabolism (2022)
Rifampin could represent an effective choice to induce a stable reduction of calcium levels in patients with HCINF1, with a good safety profile.